Intelligence Platform
Patents
Browse 30 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12415854
Antibodies to TIGIT
granted patentUS 12410170
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds
granted patentUS 12384773
Thiazole compounds and methods of use thereof
granted patentUS 12310965
Treatment of cancer utilizing an identified adenosine fingerprint
granted patentUS 12281136
Crystalline forms of a CD73 inhibitor and uses thereof
granted patentUS 12226425
Inhibitors of ARG1 and/or ARG2
granted patentUS 12195447
Azolopyrimidine for the treatment of cancer-related disorders
granted patentUS 12168023
Inhibitors of adenosine 5β²-nucleotidase
granted patentUS 12103907
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
granted patentUS 12071411
Inhibitors of HIF-2Ξ± and methods of use thereof
granted patentUS 12064433
Pyridone A2R antagonists
granted patentUS 12054500
Arginase inhibitors
granted patentUS 11993584
Solid forms of an azolopyrimidine compound
granted patentUS 11970543
Anti-CD39 antibodies and use thereof
granted patentUS 11931343
CD73 inhibitors
granted patentUS 11820824
Antibodies to TIGIT
granted patentUS 11819512
Solid forms of a CD73 inhibitor and the use thereof
granted patentUS 11787762
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
granted patentUS 11667662
Modulators of 5β²-nucleotidase, ecto and the use thereof
granted patentUS 11649261
Crystalline forms of a CD73 inhibitor and uses thereof
granted patentUS 11633416
Oral formulations of CD73 compounds
granted patentUS 11478479
Dosing with an azolopyrimidine compound
granted patentUS 11407712
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2Ξ±
granted patentUS 11267845
Inhibitors of CD73-mediated immunosuppression
granted